Association of Disease Knowledge and Medication Adherence Among Out-Patients With Type 2 Diabetes Mellitus in Khobar, Saudi Arabia

Frontiers in Pharmacology
Dhfer Mahdi AlShaybanShazia Jamshed

Abstract

The study aimed to evaluate the association between disease knowledge and medication adherence in patients with type 2 diabetes mellitus. A cross-sectional study was conducted for three months, in patients with type 2 diabetes who visited three community pharmacies located in Khobar, Saudi Arabia. Patients' disease knowledge and their adherence to medications were documented using Arabic versions of the Michigan Diabetes Knowledge Test and the General Medication Adherence Scale respectively. Data were analyzed through SPSS version 23. Chi-square test was used to report association of demographics with adherence. Spearman's rank correlation was employed to report the relationship among HbA1c values, disease knowledge and adherence. Logistic regression model was utilized to report the determinants of medication adherence and their corresponding adjusted odds ratio. Study was approved by concerned ethical committee (IRB-UGS-2019-05-001). A total of 318 patients consented to participate in the study. Mean HbA1c value was 8.1%. A third of patients (N = 105, 33%) had high adherence and half of patients (N = 162, 50.9%) had disease knowledge between 51% - 75%. A significantly weak-to-moderate and positive correlation (ρ = 0.221, p < 0...Continue Reading

References

Jan 10, 2008·Research in Nursing & Health·Melody A Hertzog
Feb 12, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·G S CollinsC E Lloyd
Mar 11, 2011·Mayo Clinic Proceedings·Marie T Brown, Jennifer K Bussell
Nov 16, 2011·International Journal of Clinical Pharmacy·Harith Kh Al-QazazFahad Saleem
Jul 31, 2013·Frontiers in Pharmacology·Przemyslaw KardasMichal Matyjaszczyk
Feb 12, 2015·Patient Preference and Adherence·Leah L ZulligHayden B Bosworth
Jul 25, 2015·Current Diabetes Reviews·Mohamed Abdulaziz Al DawishFahad Sulaiman Al Sabaan
Jan 16, 2016·The Diabetes Educator·James T FitzgeraldGrecthen A Piatt
Jul 12, 2016·Biomarker Insights·Shariq I SherwaniMeena K Sakharkar
Jul 15, 2016·Journal of Pharmacy & Bioallied Sciences·Ibrahim Suliman Al-AboudiAsrul Akmal Shafie
Dec 21, 2016·Journal of Diabetes Research·Ali Hassan AlhaitiGeorge Binh Lenon
Oct 4, 2017·Pharmacy : Journal of Pharmacy, Education and Practice·Sawsan Abdullah AlamriMastour Safer Al Ghamdi
Oct 4, 2017·Health Promotion International·Mohamed M M Abdel-Latif, Sherif Y Saad
Oct 19, 2017·Electronic Physician·Aseel Menwer AlanaziZaid Qati Alshammari
Jun 25, 2019·Frontiers in Pharmacology·Atta Abbas NaqviMohamed Azmi Hassali
Jul 10, 2019·Saudi Medical Journal·Abdulrahman H MashiNaji J AlJohani
Sep 26, 2019·General Psychiatry·Yiran ZhangXin M Tu

❮ Previous
Next ❯

Citations

Apr 12, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Ho Thi Kim Thanh, Tran Manh Tien
Aug 20, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Md Ashraful IslamSunil Kripalani
Aug 17, 2021·Journal of Diabetes Research·Michelle Asiedu-DansoAugustina Koduah

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.